Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 9
2012 5
2013 4
2014 3
2015 1
2016 2
2017 9
2018 5
2019 8
2020 5
2021 5
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy.
Borch A, Bjerregaard AM, Araujo Barbosa de Lima V, Østrup O, Yde CW, Eklund AC, Mau-Sørensen M, Barra C, Svane IM, Nielsen FC, Funt SA, Lassen U, Hadrup SR. Borch A, et al. Among authors: ostrup o. Front Genet. 2023 Mar 23;14:1058605. doi: 10.3389/fgene.2023.1058605. eCollection 2023. Front Genet. 2023. PMID: 37035751 Free PMC article.
A Comparison of Tools for Copy-Number Variation Detection in Germline Whole Exome and Whole Genome Sequencing Data.
Gabrielaite M, Torp MH, Rasmussen MS, Andreu-Sánchez S, Vieira FG, Pedersen CB, Kinalis S, Madsen MB, Kodama M, Demircan GS, Simonyan A, Yde CW, Olsen LR, Marvig RL, Østrup O, Rossing M, Nielsen FC, Winther O, Bagger FO. Gabrielaite M, et al. Among authors: ostrup o. Cancers (Basel). 2021 Dec 14;13(24):6283. doi: 10.3390/cancers13246283. Cancers (Basel). 2021. PMID: 34944901 Free PMC article.
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study.
Schou Nørøxe D, Flynn A, Westmose Yde C, Østrup O, Cilius Nielsen F, Skjøth-Rasmussen J, Brennum J, Hamerlik P, Weischenfeldt J, Skovgaard Poulsen H, Lassen U. Schou Nørøxe D, et al. Among authors: ostrup o. Mol Oncol. 2022 Jan;16(1):206-218. doi: 10.1002/1878-0261.13015. Epub 2021 Jun 25. Mol Oncol. 2022. PMID: 34018316 Free PMC article.
Diagnostic accuracy and clinical impact of [18F]FET PET in childhood CNS tumors.
Marner L, Lundemann M, Sehested A, Nysom K, Borgwardt L, Mathiasen R, Wehner PS, Henriksen OM, Thomsen C, Skjøth-Rasmussen J, Broholm H, Østrup O, Forman JL, Højgaard L, Law I. Marner L, et al. Among authors: ostrup o. Neuro Oncol. 2021 Dec 1;23(12):2107-2116. doi: 10.1093/neuonc/noab096. Neuro Oncol. 2021. PMID: 33864083 Free PMC article.
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility - a prospective, translational study.
Nørøxe DS, Yde CW, Østrup O, Michaelsen SR, Schmidt AY, Kinalis S, Torp MH, Skjøth-Rasmussen J, Brennum J, Hamerlik P, Poulsen HS, Nielsen FC, Lassen U. Nørøxe DS, et al. Among authors: ostrup o. Mol Oncol. 2020 Nov;14(11):2727-2743. doi: 10.1002/1878-0261.12790. Epub 2020 Sep 18. Mol Oncol. 2020. PMID: 32885540 Free PMC article.
Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients - initial observations.
Nygård L, Ahlborn LB, Persson GF, Chandrananda D, Langer JW, Fischer BM, Langer SW, Gabrielaite M, Kjær A, Rosenfeld N, Mouliere F, Østrup O, Vogelius IR, Bentzen SM. Nygård L, et al. Among authors: ostrup o. PLoS One. 2020 Apr 28;15(4):e0231884. doi: 10.1371/journal.pone.0231884. eCollection 2020. PLoS One. 2020. PMID: 32343749 Free PMC article.
52 results